<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>radioresistance &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/radioresistance/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 18 Sep 2025 14:56:06 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>radioresistance &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>MiR-26b-5p Drives Radioresistance in Lung Cancer</title>
		<link>https://bioengineer.org/mir-26b-5p-drives-radioresistance-in-lung-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 18 Sep 2025 14:55:53 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[immunosuppression]]></category>
		<category><![CDATA[miR-26b-5p]]></category>
		<category><![CDATA[non-small cell lung cancer (NSCLC)]]></category>
		<category><![CDATA[radioresistance]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/mir-26b-5p-drives-radioresistance-in-lung-cancer/</guid>

					<description><![CDATA[In the constantly evolving sphere of cancer research, the intricate interplay between microRNAs and cellular processes is yielding groundbreaking insights. One such revelation has come from the recent work of Chen et al., which focuses on the role of miR-26b-5p in non-small cell lung cancer (NSCLC). This study meticulously charts the pathways through which miR-26b-5p [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">270375</post-id>	</item>
	</channel>
</rss>
